Speaker illustration

Doctor Davide Cao

Icahn School of Medicine at Mount Sinai, New York (United States of America)

Member of:

EAPCI
Heart Failure Association

TWILIGHT-HBR: Ticagrelor Monotherapy in High Bleeding Risk Patients

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiplatelet Drugs

Session: Trial Updates in ACS & PCI

Thumbnail

Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy

Event: ESC Congress 2021 - The Digital Experience

Topic: Adjunctive Pharmacotherapy

Session: Highlights from the Young in Intervention

Thumbnail

This platform is supported by

logo Novo Nordisk